- Home
- MTB vs TEVA Comparison
MTB vs TEVA Comparison
Compare MTB & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MTB | TEVA |
|---|---|---|
| Founded | 1856 | 1901 |
| Country | United States | Israel |
| Employees | 21866 | 32842 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.8B | 37.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MTB | TEVA |
|---|---|---|
| Price | $248.28 | $31.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 8 |
| Target Price | ★ $228.59 | $38.63 |
| AVG Volume (30 Days) | 1.1M | ★ 4.2M |
| Earning Date | 04-15-2026 | 04-29-2026 |
| Dividend Yield | ★ 2.78% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.87 | N/A |
| Revenue Next Year | $3.66 | $2.97 |
| P/E Ratio | ★ $13.63 | $28.19 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $174.76 | $14.99 |
| 52 Week High | $255.00 | $37.35 |
Technical Indicators
Market Signals| Indicator | MTB | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 59.60 | 42.40 |
| Support Level | $211.90 | $30.59 |
| Resistance Level | $255.00 | $32.40 |
| Average True Range (ATR) | 4.67 | 0.92 |
| MACD | -0.43 | -0.15 |
| Stochastic Oscillator | 68.52 | 33.69 |
Price Performance
Historical ComparisonAbout MTB M&T Bank Corporation
M&T Bank is a US regional bank with around $215 billion in assets as of the end of the first quarter of 2026. Headquartered in Buffalo, New York, the bank's footprint is mostly concentrated in New England and the US Mid-Atlantic. M&T Bank boasts a community banking approach, and boasts over 900 branches in 13 states and Washington, D.C. Apart from retail and commercial banking, M&T Bank also has wealth management operations through Wilmington Trust and a partnership with LPL Financial, and a corporate trust business.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.